Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Titel:
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Auteur:
Motzer, Robert J. Russo, Paul Grünwald, Viktor Tomita, Yoshihiko Zurawski, Bogdan Parikh, Omi Buti, Sebastiano Barthélémy, Philippe Goh, Jeffrey C. Ye, Dingwei Lingua, Alejo Lattouf, Jean-Baptiste Albigès, Laurence George, Saby Shuch, Brian Sosman, Jeffrey Staehler, Michael Vázquez Estévez, Sergio Simsek, Burcin Spiridigliozzi, Julia Chudnovsky, Aleksander Bex, Axel